Table 1 Selected descriptive characteristics of cases (overall and according to source of case ascertainment) and controls in the study of brain cancer among active component military personnel

From: Serially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel

Characteristic

Controls N = 457 (%)

Cases N = 457 (%)

ACTUR N = 162 (%)

DMSS N = 295 (%)

Sexa

  Male

406 (88.8)

406 (88.8)

142 (87.7)

264 (89.5)

  Female

51 (11.1)

51 (11.1)

20 (12.4)

31 (10.5)

 Racea

  White

371 (81.2)

371 (81.2)

130 (80.3)

241 (81.7)

  Black

52 (11.4)

52 (11.4)

23 (14.2)

29 (9.8)

  Other

16 (3.5)

16 (3.5)

2 (1.2)

14 (4.8)

  Unknown

18 (3.9)

18 (3.9)

7 (4.3)

11 (3.7)

Reference age (years)a,b

  18–20

37 (8.1)

38 (8.3)

16 (9.9)

22 (7.5)

  21–24

94 (20.6)

95 (20.8)

34 (21.0)

61 (20.7)

  25–29

99 (21.7)

99 (21.7)

36 (22.2)

63 (21.4)

  30–34

69 (15.1)

69 (15.1)

24 (14.8)

45 (15.3)

  35–39

82 (17.9)

80 (17.5)

31 (19.1)

49 (16.6)

  40–61

76 (16.6)

76 (16.6)

21 (13.0)

55 (18.6)

Year of birtha

  1945–1963

81 (17.7)

81 (17.7)

45 (27.8)

36 (12.2)

  1964–1969

79 (17.3)

78 (17.1)

43 (26.5)

35 (11.9)

  1970–1974

105 (23.0)

99 (21.7)

36 (22.2)

63 (21.4)

  1975–1983

106 (23.2)

111 (24.3)

29 (17.9)

82 (27.8)

  1984–1991

86 (18.8)

88 (19.3)

9 (5.6)

79 (26.8)

Military serviceb,c

  Army

163 (35.7)

164 (35.9)

67 (41.4)

97 (32.9)

  Navy

156 (34.1)

118 (25.8)

44 (27.2)

74 (25.1)

  Air force

63 (13.8)

104 (22.8)

31 (19.1)

73 (24.8)

  Marines

74 (16.2)

61 (13.4)

19 (11.7)

42 (14.2)

  Coast guard

1 (0.2)

10 (2.2)

1 (0.6)

9 (3.1)

Number of pre-diagnostic serum samplesa

  One

71 (15.5)

70 (15.3)

41 (25.3)

29 (9.8)

  Two

80 (17.5)

81 (17.7)

36 (22.2)

45 (15.3)

  Three

306 (67.0)

306 (67.0)

85 (52.5)

221 (74.9)

Time between serum collection and reference year (years)c,d

  1.0–1.8

287 (25.0)

286 (24.9)

56 (15.2)

230 (29.4)

  1.9–3.5

280 (24.4)

282 (24.5)

110 (29.9)

172 (22.0)

  3.6–7.1

282 (24.5)

286 (24.9)

97 (26.4)

189 (24.2)

  7.2–22.1

300 (26.1)

296 (25.7)

105 (28.5)

191 (24.4)

  1. ACTUR automated central tumour registry, DMSS defense medical surveillance system
  2. aMatching variables
  3. bAge at diagnosis of brain cancer/glioma for cases and respective date for controls
  4. cP value for test of heterogeneity of proportions in all cases and controls <0.001
  5. dFor all serum samples